Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 186

1.

Complementary and alternative medicine use among paediatric emergency department patients.

Taylor DM, Dhir R, Craig SS, Lammers T, Gardiner K, Hunter K, Joffe P, Krieser D, Babl FE.

J Paediatr Child Health. 2015 Apr 14. doi: 10.1111/jpc.12898. [Epub ahead of print]

PMID:
25872659
2.

Steroid unresponsive case of ulcerative mucha-habermann disease (febrile ulcernecrotic mucha-habermann disease) treated with methotrexate.

Shah DJ, Dhir R, Shah H, Chawla N.

Indian J Dermatol. 2014 Nov;59(6):631. doi: 10.4103/0019-5154.143572.

3.

Renal medullary carcinoma: case report of an aggressive malignancy with near-complete response to dose-dense methotrexate, vinblastine, Doxorubicin, and Cisplatin chemotherapy.

Amjad AI, Ali H, Appleman LJ, Maranchie J, Jackman S, Parwani A, Dhir R, Roy S, Parikh RA.

Case Rep Oncol Med. 2014;2014:615895. doi: 10.1155/2014/615895. Epub 2014 Aug 19.

4.

Argument for prostate cancer screening in populations of African-Caribbean origin.

Patrick A, Bunker C, Nelson J, Dhir R, Wheeler V, Zmuda J, Richard JR, Belle A, Kuller L.

BJU Int. 2014 Jul 21. doi: 10.1111/bju.12869. [Epub ahead of print]

PMID:
25046681
5.

Improved protocol for somatic embryogenesis and calcium alginate encapsulation in Anethum graveolens L.: a medicinal herb.

Dhir R, Shekhawat GS, Alam A.

Appl Biochem Biotechnol. 2014 Aug;173(8):2267-78. doi: 10.1007/s12010-014-1032-x. Epub 2014 Jun 29.

PMID:
24974170
6.

Research and Education Foundation: celebrating 20 years of success: Supporting family medicine for a healthy Canada.

Dhir R.

Can Fam Physician. 2014 Jun;60(6):583, 584. English, French. No abstract available.

7.

Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.

Jain S, Roy S, Amin M, Acquafondata M, Yin M, Laframboise W, Bastacky S, Pantanowitz L, Dhir R, Parwani A.

Am J Surg Pathol. 2013 Dec;37(12):1824-30. doi: 10.1097/PAS.0000000000000108.

PMID:
24225843
8.

Frozen section diagnosis: is there discordance between what pathologists say and what surgeons hear?

Roy S, Parwani AV, Dhir R, Yousem SA, Kelly SM, Pantanowitz L.

Am J Clin Pathol. 2013 Sep;140(3):363-9. doi: 10.1309/AJCPHUE5ENZDU4DJ.

9.

Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.

Ai J, Pascal LE, O'Malley KJ, Dar JA, Isharwal S, Qiao Z, Ren B, Rigatti LH, Dhir R, Xiao W, Nelson JB, Wang Z.

Oncogene. 2014 May 1;33(18):2286-94. doi: 10.1038/onc.2013.190. Epub 2013 May 27.

10.

Genetic variation in ESR2 and estrogen receptor-beta expression in lung tumors.

Song JY, Siegfried JM, Diergaarde B, Land SR, Bowser R, Stabile LP, Dacic S, Dhir R, Nukui T, Romkes M, Weissfeld JL.

Cancer Epidemiol. 2013 Aug;37(4):518-22. doi: 10.1016/j.canep.2013.03.020. Epub 2013 Apr 23.

11.

Temporal effects of ethanol consumption on energy homeostasis, hepatic steatosis, and insulin sensitivity in mice.

Carr RM, Dhir R, Yin X, Agarwal B, Ahima RS.

Alcohol Clin Exp Res. 2013 Jul;37(7):1091-9. doi: 10.1111/acer.12075. Epub 2013 Feb 7.

12.

Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.

Mosquera JM, Beltran H, Park K, MacDonald TY, Robinson BD, Tagawa ST, Perner S, Bismar TA, Erbersdobler A, Dhir R, Nelson JB, Nanus DM, Rubin MA.

Neoplasia. 2013 Jan;15(1):1-10.

13.

Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography.

LaFramboise WA, Dhir R, Kelly LA, Petrosko P, Krill-Burger JM, Sciulli CM, Lyons-Weiler MA, Chandran UR, Lomakin A, Masterson RV, Marroquin OC, Mulukutla SR, McNamara DM.

BMC Med. 2012 Dec 5;10:157. doi: 10.1186/1741-7015-10-157.

14.

Using the epigenetic field defect to detect prostate cancer in biopsy negative patients.

Truong M, Yang B, Livermore A, Wagner J, Weeratunga P, Huang W, Dhir R, Nelson J, Lin DW, Jarrard DF.

J Urol. 2013 Jun;189(6):2335-41. doi: 10.1016/j.juro.2012.11.074. Epub 2012 Nov 15.

15.

Clinical integration of next-generation sequencing technology.

Gullapalli RR, Lyons-Weiler M, Petrosko P, Dhir R, Becich MJ, LaFramboise WA.

Clin Lab Med. 2012 Dec;32(4):585-99. doi: 10.1016/j.cll.2012.07.005. Review.

16.

Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression.

Imai Y, Boyle S, Varela GM, Caron E, Yin X, Dhir R, Dhir R, Graham MJ, Ahima RS.

Physiol Genomics. 2012 Nov 15;44(22):1125-31. doi: 10.1152/physiolgenomics.00045.2012. Epub 2012 Sep 25.

17.

Biomarkers of phenethyl isothiocyanate-mediated mammary cancer chemoprevention in a clinically relevant mouse model.

Singh SV, Kim SH, Sehrawat A, Arlotti JA, Hahm ER, Sakao K, Beumer JH, Jankowitz RC, Chandra-Kuntal K, Lee J, Powolny AA, Dhir R.

J Natl Cancer Inst. 2012 Aug 22;104(16):1228-39. doi: 10.1093/jnci/djs321. Epub 2012 Aug 2.

18.

Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration.

Sun Z, Miller RA, Patel RT, Chen J, Dhir R, Wang H, Zhang D, Graham MJ, Unterman TG, Shulman GI, Sztalryd C, Bennett MJ, Ahima RS, Birnbaum MJ, Lazar MA.

Nat Med. 2012 Jun;18(6):934-42. doi: 10.1038/nm.2744.

19.

Renal cell neoplasms contain shared tumor type-specific copy number variations.

Krill-Burger JM, Lyons MA, Kelly LA, Sciulli CM, Petrosko P, Chandran UR, Kubal MD, Bastacky SI, Parwani AV, Dhir R, LaFramboise WA.

Am J Pathol. 2012 Jun;180(6):2427-39. doi: 10.1016/j.ajpath.2012.01.044. Epub 2012 Apr 3.

20.

Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.

Beltran H, Rickman DS, Park K, Chae SS, Sboner A, MacDonald TY, Wang Y, Sheikh KL, Terry S, Tagawa ST, Dhir R, Nelson JB, de la Taille A, Allory Y, Gerstein MB, Perner S, Pienta KJ, Chinnaiyan AM, Wang Y, Collins CC, Gleave ME, Demichelis F, Nanus DM, Rubin MA.

Cancer Discov. 2011 Nov;1(6):487-95. doi: 10.1158/2159-8290.CD-11-0130.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk